QoR-15 scores after surgery. by Rong Tang (130779)

Subjects:

THS exposure in conjunction with antioxidant treatment for 2.5 and 5 months alleviates metabolic syndrome in a dose-dependent manner. by Neema Adhami (516427)

“…<p><b>(A)</b> THS-exposed mice treated with antioxidants for 5 months have reduced visceral fat accumulation compared to THS exposed mice. …”

SgG2 modifies NGF-TrkA signaling. by Jorge Rubén Cabrera (685511)

SgG2 promotes the incorporation of TrkA into different microdomains of the plasma membrane. by Jorge Rubén Cabrera (685511)

Original data (a, b, c, d) and disproportionality analysis results (ROR & IC). by Mengsi Peng (12882734)

Results for right lower limb joint power. by Eric Yung-Sheng Su (13015474)

SgG2 increases NGF-dependent axonal growth. by Jorge Rubén Cabrera (685511)

Table 2_Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report.docx by Oksana Boyarchuk (8910488)

“…</p>Objective<p>Present a clinical case of fatal HLH associated with a novel SH2D1A variant, highlighting the variability of clinical presentation and the potential role of co-infections.…”

Table 1_Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report.docx by Oksana Boyarchuk (8910488)

“…</p>Objective<p>Present a clinical case of fatal HLH associated with a novel SH2D1A variant, highlighting the variability of clinical presentation and the potential role of co-infections.…”

Table 3_Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report.docx by Oksana Boyarchuk (8910488)

“…</p>Objective<p>Present a clinical case of fatal HLH associated with a novel SH2D1A variant, highlighting the variability of clinical presentation and the potential role of co-infections.…”

Validation of RNA-sequencing by Q-PCR and effects of 5Aza-dC on a subset of DM and DE genes in CESC and OESC. by Iveta Yotova (451965)

“…<b>A)</b> The relative expression of <i>SLC22A23</i> under treatment with 5aza-dC increases in CESC as well as in OESC. …”

Excel spreadsheet containing, in separate sheets, the numerical data for figure panels Figs 1B, 1C, 1E, 1F, 1G, 1I, 1K, 1M, 1N, 1O, 2B, 2C, 2E, 2F, 2G, 2I, 2K, 2M, 2N, 3A, 3B, 3C,... by Le Liang (2144725)

Potential pathways of lithium action on autophagy and GFAP expression. by Christine M. LaPash Daniels (796881)

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

The staining percentages of TLR1-TLR10 in epithelial layers, basement membrane (BM) zone, endothelium and in the infiltrative zone. by Peter Rusanen (4252870)

Results from a log-binomial regression model of seroprevalence to long-term antigens (AMA-1, GLURP-R2, MSP1-19, N = 5,152 unadjusted, 5,085 adjusted, individuals), and short-term a... by Daniel J. Bridges (12050007)

Comparison of the staining percentages of TLR1-TLR10 between infiltrative zone (inf) and adjacent normal appearing epithelium in oral squamous cell carcinoma samples (OSCC; n = 30)... by Peter Rusanen (4252870)

Hazard ratios for mortality and ICU admission according to groups stratified by radiographic trajectory. by Jin Young Kim (271185)

Subjects:

Patient flow diagram. by Jin Young Kim (271185)

Subjects:

Characteristics between group 3 and group 4 as differentiated during radiologic follow-up. by Jin Young Kim (271185)

Subjects: